Literature DB >> 15461929

Transendothelial movement of liposomes in vitro mediated by cancer cells, neutrophils or histamine.

Felicia Antohe1, Lei Lin, Grace Y Kao, Mark J Poznansky, Theresa M Allen.   

Abstract

A two-chamber culture system has been used to examine the ability of small liposomes to cross an endothelial cell barrier in response to various stimuli. Transendothelial transit of liposomes was almost negligible in the presence of intact, healthy endothelial cells (EC). Addition of histamine induced a concentration-dependent increase in the movement of liposomes across the EC monolayer. In the presence of polymorphonuclear neutrophils (PMNs), migrating in response to a chemotactic gradient of N-Formil-Met-Leu-Phe (fMLP), both liposomes and IgG crossed EC monolayer by a paracellular pathway, largely independent of an association with the PMNs. The presence of cancer cell, growing in the lower chamber or the presence of cancer cell-conditioned media, also resulted in the passage of liposome across the EC. We conclude that EC monolayers are sufficiently disrupted by several physiologically relevant stimuli to allow for the transendothelial passage of liposomes. These results have important implications for the therapeutic use of liposome in the treatment of cancer or other inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461929     DOI: 10.1081/lpr-120039660

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  4 in total

Review 1.  The use of lipid-based nanocarriers for targeted pain therapies.

Authors:  Susan Hua; Sherry Y Wu
Journal:  Front Pharmacol       Date:  2013-11-21       Impact factor: 5.810

2.  Liposomal Delivery Improves the Efficacy of Prednisolone to Attenuate Renal Inflammation in a Mouse Model of Acute Renal Allograft Rejection.

Authors:  Carla M A van Alem; Martina Schmidbauer; Song Rong; Katja Derlin; Jessica Schmitz; Jan H Bräsen; Anja Thorenz; Rongjun Chen; Jurjen M Ruben; Elizabeth M Winter; Maaike Schilperoort; Sander Kooijman; Reshma A Lalai; Josbert M Metselaar; Christian Klemann; Martin Meier; Cees van Kooten; Faikah Gueler; Joris I Rotmans
Journal:  Transplantation       Date:  2020-04       Impact factor: 5.385

Review 3.  Advances and Challenges of Liposome Assisted Drug Delivery.

Authors:  Lisa Sercombe; Tejaswi Veerati; Fatemeh Moheimani; Sherry Y Wu; Anil K Sood; Susan Hua
Journal:  Front Pharmacol       Date:  2015-12-01       Impact factor: 5.810

Review 4.  Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2013-10-04       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.